Catalyst Wire Dossier Catalyst Wire Dossier

APONVIE

APREPITANT · Heron Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for APONVIE, covering 2022-09-16 to 2024-03-05. Get the full timeline:

Most recent: FDA Approved: APONVIE — Supplemental Application (Heron Therapeutics, Inc.)

See pricing